MauermannWJ, RehfeldtKH, BellMR, LowsonSM. Percutaneous coronary interventions and antiplatelet therapy in the perioperative period. J Cardiothorac Vasc Anesth2007; 21: 436–42
2.
MetzlerH, Kozek-LangeneckerS, HuberK. Antiplatelet therapy and coronary stents in perioperative medicine–the two sides of the coin. Best Pract Res Clin Anaesthesiol2008; 22: 81–94
3.
YusufS, ZhaoF, MehtaSR, ChrolaviciusS, TognoniG, FoxKK; Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med2001; 345: 494–502
4.
SabatineMS, CannonCP, GibsonCM, Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med2005; 352: 1179–89
5.
ChenZM, JiangLX, ChenYP, Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: Randomised placebo-controlled trial. Lancet2005; 366: 1607–21
6.
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE steering committee. Lancet1996; 348: 1329–39
7.
SteinhublSR, BergerPB, MannJT, Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial. JAMA2002; 288: 2411–20
8.
SabatineMS, CannonCP, GibsonCM, Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: The PCI-CLARITY study. JAMA2005; 294: 1224–32
9.
MehtaSR, YusufS, PetersRJ, Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study. Lancet2001; 358: 527–33
10.
BhattDL, FoxKA, HackeW, Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med2006; 354: 1706–17
11.
BhattDL, FlatherMD, HackeW, Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol2007; 49: 1982–8
12.
GrinesCL, BonowRO, CaseyDE, Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: A science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Catheter Cardiovasc Interv2007; 69: 334–40
13.
SilberS, AlbertssonP, AvilésFF, Guidelines for percutaneous coronary interventions. The task force for percutaneous coronary interventions of the European Society of Cardiology. Eur Heart J2005; 26: 804–47
14.
Joint British recommendations on prevention of coronary heart disease in clinical practice: Summary. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, British Diabetic Association. BMJ2000; 320: 705–8
15.
EastonJD. Evidence with antiplatelet therapy and adp-receptor antagonists. Cerebrovasc Dis2003;16 (Suppl. 1):20–6
16.
RoblessP, MikhailidisDP, StansbyG. Systematic review of antiplatelet therapy for the prevention of myocardial infarction, stroke or vascular death in patients with peripheral vascular disease. Br J Surg2001; 88: 787–800
17.
ChassotPG, DelabaysA, SpahnDR. Perioperative antiplatelet therapy: The case for continuing therapy in patients at risk of myocardial infarction. Br J Anaesth2007; 99: 316–28
BrilakisES, BanerjeeS, BergerPB. Perioperative management of patients with coronary stents. J Am Coll Cardiol2007; 49: 2145–50
20.
WilhiteDB, ComerotaAJ, SchmiederFA, ThromRC, GaughanJP, RaoAK. Managing PAD with multiple platelet inhibitors: The effect of combination therapy on bleeding time. J Vasc Surg2003; 38: 710–13
21.
PickardAS, BeckerRC, SchumockGT, FryeCB. Clopidogrel-associated bleeding and related complications in patients undergoing coronary artery bypass grafting. Pharmacotherapy2008; 28: 376–92
22.
ChuMW, WilsonSR, NovickRJ, StittLW, QuantzMA. Does clopidogrel increase blood loss following coronary artery bypass surgery?Ann Thorac Surg2004; 78: 1536–41
23.
QureshiAI, SaadM, ZaidatOO, Intracerebral hemorrhages associated with neurointerventional procedures using a combination of antithrombotic agents including abciximab. Stroke2002; 33: 1916–19
24.
VialJH, McLeodLJ, RobertsMS. Rebound elevation in urinary thromboxane B2 and 6-keto-pgf1 alpha excretion after aspirin withdrawal. Adv Prostaglandin Thromboxane Leukot Res1991; 21A: 157–60
25.
ColletJP, MontalescotG, BlanchetB, Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes. Circulation2004; 110: 2361–7
26.
KałuzaGL, JosephJ, LeeJR, RaiznerME, RaiznerAE. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol2000; 35: 1288–94
27.
SharmaAK, AjaniAE, HamwiSM, Major noncardiac surgery following coronary stenting: When is it safe to operate?Catheter Cardiovasc Interv2004; 63: 141–5
28.
PfistererM, Brunner-La RoccaHP, BuserPT, Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: An observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol2006; 48: 2584–91
29.
Biondi-ZoccaiGG, LotrionteM, AgostoniP, A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J2006; 27: 2667–74
